When is GNCC Capital’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GNCC Capital’s earnings last quarter?
GNCC Capital released its earnings results on Jul 20, 2021. The company reported $0 earnings per share for the quarter.
Is GNCC Capital overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does GNCC Capital pay dividends?
GNCC Capital does not currently pay dividends.
What is GNCC Capital’s EPS estimate?
GNCC Capital’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GNCC Capital have?
GNCC Capital has 174,144,780,000 shares outstanding.
What happened to GNCC Capital’s price movement after its last earnings report?
GNCC Capital reported an EPS of $0 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of GNCC Capital?
Currently, no hedge funds are holding shares in GNCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GNCC Capital
GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S., specializes in the production and marketing of pharmaceutical-grade CBD oils derived from cannabis. These products are distributed via established networks throughout Colombia and across the broader Latin American market. The parent company's headquarters are located in Las Vegas, Nevada.
Sector
Basicmaterials
Industry
Gold
CEO
Nicolaas Edward Blom
Employees
900
Website
www.gncc-capital.com
Address
848 North Rainbow Boulevard, Las Vegas, NV, 89107, US